The in silico analysis of 101,562 tumor samples performed during this study revealed 17 unique variants in the SLC34A2 gene leading to alterations in the amino acid sequence within the MX35 epitope (311–340 aa) of the NaPi2b transporter. Here, SLC34A2 is linked to neoplasm.